Donggwang Linagliptin Tablet 5 mg
Linagliptin 5mg
Tablet · Prescription medication
Donggwang Pharmaceutical Co., Ltd.
MFDS item code 202000323 · Approved 2020.01.21
Improvement of blood sugar control in type 2 diabetes
This drug can be used together with diet and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can also be used alone, and when there is difficulty in blood sugar control in patients with no prior diabetes treatment experience, it is administered in combination with metformin. It can be combined with metformin or sulfonylurea when blood sugar control is not satisfactory with monotherapy. Additionally, it can be used as an add-on therapy for patients who are on insulin therapy but still have insufficient blood sugar control. If blood sugar control remains difficult even after combination therapy of sulfonylurea and metformin or empagliflozin and metformin, this drug can be used in combination to enhance control. Therefore, this drug is effectively used at various stages of treatment to assist in blood sugar control.
The recommended dosage of this drug is 5 mg once daily. It can be taken regardless of meals.
This drug should not be used in patients who have allergic reactions to the active ingredient or other components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Careful use is necessary when this drug is used with other medications such as insulin or sulfonylureas that may induce hypoglycemia due to increased risk. Experience in administering this drug to patients with heart failure is limited, so it should be used cautiously. Symptoms of acute pancreatitis may occur; therefore, if severe abdominal pain persists, discontinue use immediately and consult a doctor. A skin condition resembling bullous pemphigoid may occur, so patients should inform a doctor immediately if blisters or erosion appear on the skin. Hypoglycemic symptoms may occur during treatment; appropriate measures should be taken if symptoms arise. The use of this drug is not recommended for pregnant or breastfeeding women, especially during pregnancy as safety has not been established. Its safety and efficacy have not been sufficiently confirmed in children and adolescents, so it is not recommended for them. It can be used in elderly patients without special dose adjustments, and patients with decreased kidney or liver function can also use it without dose adjustments. In cases of overdose, non-absorbed medication should be removed from the gastrointestinal tract, and clinical symptoms should be monitored with necessary treatment. This drug must be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a closed container to protect it from air and moisture, preferably at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy over time.
Bright red film-coated round tablets
30 tablets/box [(10 tablets/PTP) x 3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 5mg
Tablet · Prescription medication
Donggwang Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.